Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: July 18, 2023
Abstract
Osteosarcoma
is
a
heterogeneous
disease
with
regard
to
its
chemotherapy
response
and
clinical
outcomes.
This
study
aims
investigate
the
genomic
transcriptomic
characteristics
related
pre-operative
response.
Samples
from
25
osteosarcoma
patients
were
collected
perform
both
whole
exome
transcriptome
sequencing.
had
relatively
high
level
of
chromosomal
copy
number
variant
(CNV)
burden.
Chemotherapy
responders
showed
higher
CNV
burden
than
non-responders
(p
=
0.0775).
The
percentage
COSMIC
signature
3,
associated
homologous
recombination
repair
deficiency,
was
in
(56%)
(45%).
Transcriptomic
analysis
suggested
that
11
genes
significantly
up-regulated
18
non-responders.
Both
GSEA
KEGG
enrichment
indicted
four
pathways
cardiomyopathy
responders,
while
neuroactive
ligand−receptor
interaction
Finally,
random
forest-based
classifier
developed
classify
using
23
differentially
expressed
genes,
area
under
curve
0.843
(95%
CI,
0.654-1.000).
mutational
profile
frequent
occurrence
CNVs.
identified
several
signaling
responsiveness
osteosarcoma.
provides
potential
research
direction
for
predicting
Cell Proliferation,
Journal Year:
2023,
Volume and Issue:
56(12)
Published: June 14, 2023
Osteoarthritis
is
a
progressive
and
heterogeneous
joint
disease
with
complex
pathogenesis.
The
various
phenotypes
associated
each
patient
suggest
that
better
subgrouping
of
tissues
genotypes
in
different
phases
osteoarthritis
may
provide
new
insights
into
the
onset
progression
disease.
Recently,
single-cell
RNA
sequencing
was
used
to
describe
pathogenesis
on
high-resolution
view
surpassing
traditional
technologies.
Herein,
this
review
summarizes
microstructural
changes
articular
cartilage,
meniscus,
synovium
subchondral
bone
are
mainly
due
crosstalk
amongst
chondrocytes,
osteoblasts,
fibroblasts
endothelial
cells
during
progression.
Next,
we
focus
promising
targets
discovered
by
its
potential
applications
target
drugs
tissue
engineering.
Additionally,
limited
amount
research
evaluation
bone-related
biomaterials
reviewed.
Based
pre-clinical
findings,
elaborate
clinical
values
for
therapeutic
strategies
osteoarthritis.
Finally,
perspective
future
development
patient-centred
medicine
therapy
combining
other
multi-omics
technologies
discussed.
This
will
cellular
level
field
personalized
therapeutics
future.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Sept. 12, 2022
Background
The
main
objective
of
this
study
was
to
analyze
the
effects
KRAS/TP53
mutation
status
and
tumor
sideness
on
immune
microenvironment
colorectal
cancer
using
integrated
scRNA-seq
data.
Methods
A
total
78
datasets,
comprising
42
treatment-naive
tumors,
13
adjacent
tissues
23
normal
mucosa
were
included.
Standardized
Seurat
procedures
applied
identify
cellular
components
with
canonical
cell
marks.
batch-effect
assessed
corrected
harmony
algorithm.
scMetabolism
algorithm
used
for
single-cell
metabolic
analysis.
results
clinical
significance
further
validated
immunofluorescent-staining
TCGA-COAD
datasets.
Immune-infiltration
scores
bulk-RNA-seq
data
estimated
ssGSEA.
presto-wilcoxauc
differentially
enriched
genes
or
pathways
across
different
subgroups.
Two-sided
p-value
less
than
0.05
considered
statistically
significant.
Results
We
refined
landscape
functional
subtypes,
especially
T
cells
myeloid
cells,
mucosa,
tissue.
existence
function
two
states
exhausted
CD8
+
(Tex)
subtypes
in
cancer,
FOLR2
LYVE1
macrophages
indicating
unfavorable
prognosis
identified
validated.
diverse
reshaped
checkpoint
ligands/receptors
(ICLs/ICRs)
expression
pattern.
Importantly,
dual
mutations
significantly
reduced
major
energy
functions
promoted
cell-to-cell
communications
towards
immunosuppression
cancers.
revealed
LAG3,
CD24-SIGLEC10
HBEGF-CD9
as
potential
therapeutic
targets
mutant
Conclusions
that
underwent
a
gradual
remodeling
an
enrichment
immunosuppressive
from
regions
Moreover,
we
heterogeneity
tumor-infiltrating
suggested
may
impair
antitumor
immunity
by
reducing
metabolism
reshaping
interactions
toward
immunosuppression.
Bosnian Journal of Basic Medical Sciences,
Journal Year:
2022,
Volume and Issue:
22(6), P. 912 - 922
Published: June 23, 2022
Immune
cell
infiltration
plays
an
essential
role
in
the
occurrence
and
development
of
colon
cancer.
However,
main
tumor-associated
immune
its
gene
regulation
cancer
still
need
to
be
further
clarified
order
provide
a
new
perspective
for
diagnosing
treating
this
disease.
For
study,
single-cell
RNA
sequencing
(scRNA-seq)
expression
profiles
TCGA
data
sets
were
first
acquired
from
GEO
database.
Then,
Seurat,
Monocle,
LIMMA,
Clusterprofile,
GSVA
GSEABase
algorithms
used
systematically
examine
data.
Potential
target
drugs
corresponding
genes
analyzed
Drugbank
database
detected
by
molecular
docking.
Immunohistochemistry
was
assess
level
C1QC
tissue
microarray.
Single
analysis
suggested
that
neutrophil
activation
might
critical
regulatory
pathway
macrophages
population
involved.
Subsequent
functional
enrichment
on
differential
may
factor
progression
cancer,
closely
related
survival
patients.
According
drug
prediction,
palivizumab
is
targeted
C1QC,
docking
demonstrated
binds
C1QC.
Additionally,
tissue-microarray
based
immunohistochemical
showed
highly
expressed
tissue,
prognosis
patients
with
high
worse,
age,
lymphatic
metastasis
TNM
stage
(Tumor,
Nodes
Metastases).
Our
findings
suggest
regulate
infiltration,
which
expected
potential
immunotherapy
beneficial
diagnosis
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 11, 2024
Osteosarcoma
is
a
common
type
of
bone
cancer
characterized
by
poor
prognosis
due
to
its
metastatic
nature.
The
tumor
microenvironment
(TME)
plays
critical
role
in
metastasis
and
therapy
response.
Therefore,
our
study
aims
explore
the
mechanism
osteosarcoma,
potentially
opening
new
avenues
for
treatment.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 18, 2024
Osteosarcoma
has
a
unique
tumor
microenvironment
(TME),
which
is
characterized
as
complex
comprising
of
bone
cells,
immune
stromal
and
heterogeneous
vascular
structures.
These
elements
are
intricately
embedded
in
mineralized
extracellular
matrix,
setting
it
apart
from
other
primary
TMEs.
In
state
normal
physiological
function,
these
cell
types
collaborate
coordinated
manner
to
maintain
the
homeostasis
hematopoietic
systems.
However,
pathological
condition,
i.e.,
neoplastic
malignancies,
tumor-immune
(TIME)
been
shown
promote
cancer
cells
proliferation,
migration,
apoptosis
drug
resistance,
well
escape.
The
intricate
dynamic
system
TIME
osteosarcoma
involves
crucial
roles
played
by
various
infiltrating
complement
system,
exosomes.
This
complexity
closely
associated
with
evading
surveillance,
experiencing
uncontrolled
facilitating
metastasis.
this
review,
we
elucidate
interplay
between
diverse
populations
TIME,
each
contributing
uniquely
progression.
From
chondroblastic
osteoblastic
osteoclasts,
myeloid
lymphoid
subsets,
comprehensive
single-cell
analysis
provides
detailed
roadmap
ecosystem.
Furthermore,
summarize
mutations,
epigenetic
mechanisms,
vesicles
that
dictate
immunologic
landscape
modulate
osteosarcoma.
perspectives
clinical
implementation
immunotherapy
therapeutic
approaches
for
targeting
also
intensively
discussed.
Frontiers in Genetics,
Journal Year:
2022,
Volume and Issue:
13
Published: Oct. 11, 2022
Osteosarcoma
(OS)
is
a
common
bone
cancer
in
children
and
adolescents,
metastasis
recurrence
are
the
major
causes
of
poor
treatment
outcomes.
A
better
understanding
tumor
microenvironment
required
to
develop
an
effective
for
OS.
In
this
paper,
single-cell
RNA
sequencing
dataset
was
taken
systematic
genetic
analysis,
potential
signaling
pathways
linked
with
osteosarcoma
development
were
explored.
Our
findings
revealed
25
clusters
across
11
tissues,
cell
types
including
"Chondroblastic
cells",
"Osteoblastic
"Myeloid
"Pericytes",
"Fibroblasts",
"Proliferating
osteoblastic
"Osteoclasts",
"TILs",
"Endothelial
"Mesenchymal
stem
"Myoblasts".
The
results
Cell
communication
analysis
showed
17
cellular
networks
"COLLAGEN
pathway
network",
"CD99
"PTN
"MIF
"SPP1
"FN1
"LAMININ
"FGF
"VEGF
"GALECTIN
"PERIOSTIN
"VISFATIN
"ITGB2
"NOTCH
"IGF
"VWF
"PDGF
network".
This
research
may
provide
novel
insights
into
pathophysiology
OS's
molecular
processes.
Aging,
Journal Year:
2023,
Volume and Issue:
15(18), P. 9676 - 9694
Published: Sept. 19, 2023
Background:
Lung
cancer
exhibits
the
world's
highest
mortality
rate
among
malignant
cancers
worldwide,
thereby
presenting
a
significant
global
challenge
in
terms
of
reducing
patient
mortality.
In
field
oncology,
targeted
immunotherapy
has
emerged
as
novel
therapeutic
approach
for
lung
cancer.
This
study
aims
to
explore
potential
targets
adenocarcinoma
(LUAD)
through
analysis
Ferroptosis
Index
(FPI)
and
Single
Cell
RNA-Sequencing
(scRNA-seq)
data.
The
findings
this
research
can
potentially
offer
valuable
insights
improving
LUAD
strategies
informing
clinical
decision-making.
Methods:
Firstly,
relationship
between
survival
ferroptosis
patients
was
analyzed
by
FPI.
Subsequently,
association
infiltration
regulation
immune
cells
explored
correlation
statistics.
Lastly,
major
infiltrating
cell
populations
related
pathways
prognosis
GSEA
GSVA.
To
screen
out
core
genes
regulating
populations,
scRNA-seq
data
para-cancerous
tissues
were
downloaded,
followed
clustering
analysis,
identification
subpopulations,
pseudotime
single-cell
GSVA
pathway
enrichment
functional
regulatory
genes.
Moreover,
expression
levels
tissue
microarray
detected
immunohistochemistry,
its
with
verified.
Finally,
we
used
lentivirus
WDFY4
transfect
A549
cells.
CCK-8,
flow
cytometry
apoptosis
detection,
Scratch
wound
healing
assay,
Transwell
migration
Xenograft
nude
mice
model,
immunohistochemical
other
experimental
methods
biological
effects
on
vitro
vivo.
Results:
Survival
FPI
values
revealed
positive
smaller
longer
overall
survival.
Immuno-infiltration
that
B
most
strongly
associated
ferroptosis.
could
promote
activation
more
had
long-term
indicated
population
is
one
infiltrated
LUAD.
During
later
phases
differentiation
LUAD,
there
decrease
ACAP1,
LINC00926,
TLR10,
MS4A1,
WDFY4,
TRIM22
genes,
whereas
TMEM59,
TP53INP1,
METTL7A
elevated.
protein-protein
interaction
(PPI)
network
plays
crucial
role
Immunohistochemical
downregulation
expression,
which
closely
occurrence
sites
low
exhibited
poorer
prognosis.
Additionally,
demonstrated
overexpression
inhibit
proliferation
metastasis
while
promoting
apoptosis.
It
also
confirmed
growth
Conclusions:
results
indicate
improve
patients,
offering
immunotherapeutic
Besides,
promotion
upregulation
have
been
shown
induce
populations.
Furthermore,
significantly
vivo,
highlighting
target
Journal of Oncology,
Journal Year:
2022,
Volume and Issue:
2022, P. 1 - 16
Published: June 28, 2022
Gastric
cancer
(GC)
is
usually
diagnosed
in
an
advanced
stage
at
the
first
visit
due
to
atypical
clinical
symptoms.
The
low
surgical
resection
rate
and
chemotherapy
sensitivity
result
dismal
survival.
Therefore,
it
urgent
develop
novel
biomarkers
with
high
specificity
accurately
assess
prognosis
of
GC
patients.
In
present
study,
3385
differentially
expressed
genes
(DEGs)
were
obtained
from
single-cell
RNA
sequencing
data
specimens.
Using
unsupervised
dimensionality
reduction,
we
further
found
3
subsets
cells
including
gastric
cells,
plasmacytoid
dendritic
memory
T
cells.
Based
on
cell
clustering,
explored
key
regulatory
for
progression
by
pseudo-time
analysis
functional
enrichment
analysis.
According
results,
significant
fatty
acid-binding
protein
1
(FABP1)
verified
was
identified
as
hub
gene
progression.
FABP1
shown
be
closely
related
long-term
survival
age
diagnosis
patients
based
TCGA
(The
Cancer
Genome
Atlas)
database.
To
verify
role
GC,
performed
immunohistochemical
(IHC)
using
tissue
microarray
that
expression
level
higher
tissues
than
adjacent
tissues.
Moreover,
had
a
worse
outcome.
summary,
our
study
revealed
potential
effective
biomarker
predicts
unsatisfactory
Translational Cancer Research,
Journal Year:
2022,
Volume and Issue:
11(10), P. 3841 - 3852
Published: Oct. 1, 2022
Background:
Mesenchymal
stem
cells
(MSCs)
play
a
crucial
role
in
osteosarcoma
(OS)
growth
and
progression.
This
study
conducted
bioinformatics
analysis
of
single-cell
ribonucleic
acid
sequencing
data
set
explored
the
MSC-specific
differentially
expressed
genes
(DEGs)
advanced
OS.
Methods:
DEGs
from
GSE152048
was
extracted
using
Seurat
R
package.
These
were
then
subjected
to
functional
analysis,
several
key
further
identified
underwent
prognosis
analysis.
Results:
A
total
234
upregulated
280
downregulated
between
MSCs
other
cells,
188
158
osteoblastic
cells.
The
Gene
Ontology
(GO)
showed
that
specific
enriched
GO
terms
such
as
"collagen
catabolic
process",
"positive
regulation
pathway-restricted
SMAD
protein
phosphorylation",
"osteoblast
differentiation",
"regulation
release
cytochrome
c
mitochondria"
"interleukin-1
production".
protein-protein
interaction
network
Further,
survival
20
with
combined
scores
>0.94
revealed
low
expression
ANXA1
(annexin
A1)
TPM1
(tropomyosin
1)
associated
shorter
overall
OS
patients,
while
high
FDPS
(farnesyl
pyrophosphate
synthase),
IFITM5
(interferon-induced
transmembrane
5),
FKBP11
(FKBP
prolyl
isomerase
11),
SP7,
SQLE
(squalene
epoxidase)
patients.
In
we
compared
ANXA1,
FDPS,
IFITM5,
FKBP11,
SQLE,
high-grade
Further
validation
studies
GSE42352
more
than
Conclusions:
Our
7
hub
derived
may
serve
potential
prognostic
biomarkers
for
patients